Atherogenic index of plasma and risk of cardiovascular disease among Cameroonian postmenopausal women

Lipids Health Dis. 2016 Mar 9:15:49. doi: 10.1186/s12944-016-0222-7.

Abstract

Background: The paucity of data regarding the relationship between atherogenic index of plasma (AIP) and risk of cardiovascular disease (CVD) in postmenopausal women living in sub-Saharan Africa prompted us to conduct this study which aimed at assessing the interplay between AIP and risk of CVD among Cameroonian postmenopausal women.

Methods: This was a cross-sectional study conducted among 108 postmenopausal women in Yaoundé, Cameroon. Risk of CVD was calculated using the Framingham risk score, (FRS), and the AIP was derived as log (triglycerides/high-density lipoproteins cholesterol).

Results: Mean age of participants equaled 56.4 ± 6.9 years. AIP values ranged from -0.40 to 0.85 with a mean of 0.21 ± 0.27. There was a positive and significant correlation between AIP and body mass index (r = 0.234; p = 0.015), systolic blood pressure (r = 0.350; p < 0.001), diastolic blood pressure (r = 0.365; p < 0.001), fasting plasma glucose (r = 0.314; p = 0.001), uric acid (r = 0.374; p < 0.001), and total cholesterol (r = 0.374; p < 0.001), but not with age (r = -0.104; p = 0.284). The FRS varied between 1.2 % and >30 % with a mean of 13.4 ± 8.7 %. In univariable model, AIP significantly influenced the risk of CVD (β = 11.94; p < 0.001; R(2) = 0.136). But in the multivariable model, after adjusting for confounders, AIP did not impact the risk of CVD anymore (adjusted β = 1.98; p = 0.487; R(2) = 0.486).

Conclusion: AIP may not be an independent factor impacting the risk of CVD among Cameroonian postmenopausal women. More studies are needed to better elucidate the interaction between AIP and risk of CVD in our setting.

MeSH terms

  • Aged
  • Atherosclerosis / blood
  • Blood Glucose / metabolism
  • Blood Pressure / physiology
  • Cameroon
  • Cardiovascular Diseases / blood*
  • Cholesterol / blood
  • Cross-Sectional Studies
  • Female
  • Humans
  • Middle Aged
  • Postmenopause / blood*
  • Risk Factors
  • Uric Acid / blood

Substances

  • Blood Glucose
  • Uric Acid
  • Cholesterol